AGT and metabolic dysfunction-associated steatotic liver disease: In addition, a large number of studies also found that Ang II blockers such as angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) can reduce the occurrence of NAFLD [16,17,18,19,20].